Emmessar Biotech & Nutrition Ltd to Approve Q4 Results on Feb 11, 2026; Trading Window Closed

Emmessar Biotech & Nutrition Ltd has announced that its Board of Directors will meet on February 11, 2026, in Mumbai to consider and approve the unaudited Financial Results for the quarter ended December 31, 2025. In accordance with the Securities and Exchange Board of India (Listing Obligations and Disclosure requirements) Regulations, 2015, and the SEBI (Prohibition of Insider Trading), Regulations, 2015, as amended from time to time, the trading window for equity shares of the company will remain closed until February 13, 2026.